Geron Corp (NASDAQ: GERN) kicked off on Monday, up 1.52% from the previous trading day, before settling in for the closing price of $1.32. Over the past 52 weeks, GERN has traded in a range of $1.17-$5.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 5.60%. While this was happening, its average annual earnings per share was recorded 52.95%. With a float of $603.39 million, this company’s outstanding shares have now reached $636.92 million.
The extent of productivity of a business whose workforce counts for 229 workers is very important to gauge. In terms of profitability, gross margin is 97.85%, operating margin of -115.49%, and the pretax margin is -119.54%.
Geron Corp (GERN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Geron Corp is 5.26%, while institutional ownership is 75.75%. The most recent insider transaction that took place on May 09 ’25, was worth 15,667. In this transaction Director of this company bought 13,300 shares at a rate of $1.18, taking the stock ownership to the 13,300 shares. Before that another transaction happened on Feb 27 ’25, when Company’s EVP, Chief Legal Officer bought 15,000 for $1.61, making the entire transaction worth $24,150. This insider now owns 26,682 shares in total.
Geron Corp (GERN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 52.95% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Take a look at Geron Corp’s (GERN) current performance indicators. Last quarter, stock had a quick ratio of 6.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.05 in one year’s time.
Technical Analysis of Geron Corp (GERN)
The latest stats from [Geron Corp, GERN] show that its last 5-days average volume of 8.78 million was inferior to 13.03 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 21.07%.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 11.41%, which indicates a significant decrease from 14.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0898 in the past 14 days, which was lower than the 0.1145 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4280, while its 200-day Moving Average is $2.6237. Now, the first resistance to watch is $1.3600. This is followed by the second major resistance level at $1.3800. The third major resistance level sits at $1.4100. If the price goes on to break the first support level at $1.3100, it is likely to go to the next support level at $1.2800. Assuming the price breaks the second support level, the third support level stands at $1.2600.
Geron Corp (NASDAQ: GERN) Key Stats
The company with the Market Capitalisation of 853.47 million has total of 636,918K Shares Outstanding. Its annual sales at the moment are 76,990 K in contrast with the sum of -174,570 K annual income. Company’s last quarter sales were recorded 39,600 K and last quarter income was -19,840 K.
